Tom Degenhardt

764 total citations
33 papers, 239 citations indexed

About

Tom Degenhardt is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Tom Degenhardt has authored 33 papers receiving a total of 239 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 15 papers in Oncology and 14 papers in Cancer Research. Recurrent topics in Tom Degenhardt's work include Advanced Breast Cancer Therapies (15 papers), Breast Cancer Treatment Studies (14 papers) and HER2/EGFR in Cancer Research (7 papers). Tom Degenhardt is often cited by papers focused on Advanced Breast Cancer Therapies (15 papers), Breast Cancer Treatment Studies (14 papers) and HER2/EGFR in Cancer Research (7 papers). Tom Degenhardt collaborates with scholars based in Germany, Switzerland and Italy. Tom Degenhardt's co-authors include Nadia Harbeck, Rachel Wuerstlein, Oleg Gluz, Tanja K. Eggersmann, Thomas Kolben, T Kolben, Ronald Kates, Sven Mahner, Jutta Engel and Nina Ditsch and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Tom Degenhardt

31 papers receiving 237 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Tom Degenhardt	136	90	87	37	25	33	239
Oraianthi Fiste	154 1.1×	84 0.9×	62 0.7×	43 1.2×	24 1.0×	40	270
Scott T.C. Shepherd	100 0.7×	39 0.4×	37 0.4×	48 1.3×	25 1.0×	17	175
Lewis Au	267 2.0×	81 0.9×	52 0.6×	88 2.4×	37 1.5×	30	396
Nancy Nixon	233 1.7×	69 0.8×	43 0.5×	64 1.7×	45 1.8×	26	348
Shyam Aggarwal	156 1.1×	60 0.7×	49 0.6×	71 1.9×	13 0.5×	22	289
Renata Colombo Bonadio	162 1.2×	58 0.6×	58 0.7×	50 1.4×	17 0.7×	42	291
Valeria Stati	182 1.3×	99 1.1×	27 0.3×	61 1.6×	29 1.2×	25	319
Aditi P. Singh	204 1.5×	208 2.3×	147 1.7×	59 1.6×	23 0.9×	41	358
Giovanni La Valle	220 1.6×	76 0.8×	189 2.2×	61 1.6×	15 0.6×	6	334
J. Casal	195 1.4×	170 1.9×	43 0.5×	40 1.1×	10 0.4×	29	327

Countries citing papers authored by Tom Degenhardt

Since Specialization

Citations

This map shows the geographic impact of Tom Degenhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Degenhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Degenhardt more than expected).

Fields of papers citing papers by Tom Degenhardt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Degenhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Degenhardt. The network helps show where Tom Degenhardt may publish in the future.

Co-authorship network of co-authors of Tom Degenhardt

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Degenhardt. A scholar is included among the top collaborators of Tom Degenhardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Degenhardt. Tom Degenhardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Köenig, Alexander, Nicole Erickson, Kerstin Hermelink, et al.. (2024). Empowering of Oncology Patients and Informal Caregivers: Analysis of an Interdisciplinary Seminar Model for Breast Cancer and Gyneco-Oncological Patients. Oncology Research and Treatment. 47(10). 509–517. 1 indexed citations

Harbeck, Nadia, Ronald Kates, Timo Schinköthe, et al.. (2023). 195P Impact of an interactive eHealth system for patient reported outcomes on safety in patients with hormone receptor positive, HER2 negative locally advanced or metastatic breast cancer treated by palbociclib and endocrine therapy. ESMO Open. 8(1). 101384–101384. 1 indexed citations

Harbeck, Nadia, Ronald Kates, Timo Schinköthe, et al.. (2023). Favorable impact of therapy management by an interactive eHealth system on severe adverse events in patients with hormone receptor-positive, HER2-negative locally advanced or metastatic breast cancer treated by palbociclib and endocrine therapy. Cancer Treatment Reviews. 121. 102631–102631. 6 indexed citations

Mayr, Doris, Elisa Schmoeckel, Tom Degenhardt, et al.. (2022). Hormone Receptor and HER2 Status Switch in Non-pCR Breast Cancer Specimens after Neoadjuvant Therapy. Breast Care. 17(5). 501–507. 2 indexed citations

Wuerstlein, Rachel, Alexander Köenig, Susanne Beyer, et al.. (2021). COVID-19 vaccination in patients with breast cancer and gynecological malignancies: A German perspective. The Breast. 60. 214–222. 21 indexed citations

Bottoni, Gianluca, Arnoldo Piccardo, Francesco Fiz, et al.. (2021). Heterogeneity of bone metastases as an important prognostic factor in patients affected by oestrogen receptor-positive breast cancer. The role of combined [18F]Fluoroestradiol PET/CT and [18F]Fluorodeoxyglucose PET/CT. European Journal of Radiology. 141. 109821–109821. 18 indexed citations

Gluz, Oleg, Tom Degenhardt, Norbert Marschner, et al.. (2021). Abstract OT-01-02: Adaptlate -a randomized, controlled, open-label, phase-iii trial on adjuvant dynamic marker - adjusted personalized therapy comparing abemaciclib combined with standard adjuvant endocrine therapy versus standard adjuvant endocrine therapy in (clinical or genomic) high risk, hr+/her2- early breast cancer. Cancer Research. 81(4_Supplement). OT–1. 1 indexed citations

Köenig, Alexander, et al.. (2019). Palbociclib in daily clinical use: Real world experience of the breast center at the University Hospital Munich. Annals of Oncology. 30. iii58–iii58. 1 indexed citations

Degenhardt, Tom, et al.. (2019). Moderne Möglichkeiten der onkoplastischen Brustchirurgie. MMW - Fortschritte der Medizin. 161(14). 47–50. 1 indexed citations

10.

Kolben, Thomas, T Kolben, Tom Degenhardt, et al.. (2019). Metastatic Breast Cancer: Is There a Differential Therapy Efficacy between Visceral and Non-Visceral Metastatic Breast Cancer?. Breast Care. 15(5). 527–533. 3 indexed citations

11.

Eggersmann, Tanja K., Tom Degenhardt, Oleg Gluz, Rachel Wuerstlein, & Nadia Harbeck. (2019). CDK4/6 Inhibitors Expand the Therapeutic Options in Breast Cancer: Palbociclib, Ribociclib and Abemaciclib. BioDrugs. 33(2). 125–135. 82 indexed citations

12.

Hermelink, Kerstin, Alex Farr, Jutta Engel, et al.. (2018). Evaluation of Reproductive Concerns and Biographical Impact of Breast Cancer in Young Patients. Breast Care. 13(2). 124–128. 4 indexed citations

13.

Kolben, Thomas, B Haberland, Tom Degenhardt, et al.. (2018). Evaluation of an interdisciplinary palliative care inhouse training for professionals in gynecological oncology. Archives of Gynecology and Obstetrics. 297(3). 767–773. 7 indexed citations

14.

Kahlert, Steffen, T Kolben, Elisa Schmoeckel, et al.. (2018). Prognostic impact of residual disease in simultaneous additional excision specimens after one-step breast conserving therapy with negative final margin status in primary breast cancer. European Journal of Surgical Oncology. 44(9). 1318–1323. 8 indexed citations

15.

Gennari, Alessandra, Étienne Brain, Oriana Nanni, et al.. (2017). Molecular imaging with 18F-fluoroestradiol (18F-FES) to assess intra-patient heterogeneity in metastatic breast cancer (MBC): A European TRANSCAN program. Annals of Oncology. 28. v31–v31. 7 indexed citations

16.

Monti, Manuela, Oriana Nanni, Arnoldo Piccardo, et al.. (2016). ERA-Net TRANSCAN JTC 2011: Critical aspects of the startup procedures of an International Academic Clinical trial (ET-FES), funded by the European Community (EC) and coordinated by an Italian Institution.. Annals of Oncology. 27. iv113–iv113.

17.

Kolben, Thomas, T Kolben, Isabelle Himsl, et al.. (2016). Local Resection of Primary Tumor in Upfront Stage IV Breast Cancer. Breast Care. 11(6). 411–417. 5 indexed citations

18.

Kolben, T, Theresa Schwarz, Cornelia Blume, et al.. (2015). Surgical management of ipsilateral breast tumor recurrence. International Journal of Surgery. 23(Pt A). 141–146. 17 indexed citations

19.

Kolben, Thomas, Doris Augustin, Robert Armbrust, et al.. (2015). Impact of guideline-based use of uPA/PAI-1 on patient outcome in intermediate-risk early breast cancer. Breast Cancer Research and Treatment. 155(1). 109–115. 10 indexed citations

20.

Degenhardt, Tom, et al.. (1981). [Bioavailability and buffer capacity of antacids. A randomized double-blind study for the comparison of the most used antacid solutions].. PubMed. 99(33). 1318–20. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact